celecoxib and cyclovirobuxine d

celecoxib has been researched along with cyclovirobuxine d in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Hu, D; Liu, X; Wang, Y	1

Other Studies

1 other study(ies) available for celecoxib and cyclovirobuxine d

Article	Year
Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2 Topics: Acute Disease; Animals; Animals, Newborn; Celecoxib; Cell Hypoxia; Cell Survival; Cells, Cultured; Coronary Thrombosis; Cyclooxygenase 2 Inhibitors; Drugs, Chinese Herbal; Endothelial Cells; Estrogen Antagonists; Glyburide; Myocardial Ischemia; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamoxifen	2007

Article

Year

Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.

European journal of pharmacology, 2007, Aug-13, Volume: 569, Issue:1-2

Topics: Acute Disease; Animals; Animals, Newborn; Celecoxib; Cell Hypoxia; Cell Survival; Cells, Cultured; Coronary Thrombosis; Cyclooxygenase 2 Inhibitors; Drugs, Chinese Herbal; Endothelial Cells; Estrogen Antagonists; Glyburide; Myocardial Ischemia; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamoxifen

2007